- RenovoRx appointed Ramtin Agah to the newly created role of Executive Chairman, effective Feb. 27, 2026.
- Agah also serves as the company’s Chief Medical Officer and Chairman of the Board.
- The board formalized the appointment on March 24, 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RenovoRx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-013080), on March 27, 2026, and is solely responsible for the information contained therein.
Comments